Detalhe da pesquisa
1.
Effect of chronic cabergoline treatment and testosterone replacement on metabolism in male patients with prolactinomas.
Neuroendocrinology
; 101(1): 66-81, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25592453
2.
SARS-CoV-2 in Kidney Transplant Patients: A Real-Life Experience.
Front Med (Lausanne)
; 9: 864865, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35419375
3.
Stepwise shortening of agalsidase beta infusion duration in Fabry disease: Clinical experience with infusion rate escalation protocol.
Mol Genet Genomic Med
; 9(5): e1659, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33755336
4.
Switch from enzyme replacement therapy to oral chaperone migalastat for treating fabry disease: real-life data.
Eur J Hum Genet
; 28(12): 1662-1668, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32647377
5.
Eradication of HCV in Renal Transplant Recipients and Its Effects on Quality of Life.
Biomed Res Int
; 2018: 8953581, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30246027
6.
Cabergoline use for pituitary tumors and valvular disorders.
Endocrinol Metab Clin North Am
; 44(1): 89-97, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25732645
7.
Safety of long-term treatment with cabergoline on cardiac valve disease in patients with prolactinomas.
Eur J Endocrinol
; 169(3): 359-66, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23824978